ArticleCureus2025
Variable Presentations of Sclerosing Pneumocytoma: Two Cases Highlighting Divergent Fluorodeoxyglucose Metabolism and Carcinoid Tumorlet Association.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Endobronchial Pulmonary Typical Carcinoid Tumors in Young Adults: A Three-Case Series Highlighting Obstructive Complications and Surgical Outcomes.Cancer management and research · 2026Article
- Parenchyma-Sparing Bronchial Sleeve Resection for Central Typical Endobronchial Pulmonary Carcinoid in a Young Adult: A Case Report.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary sclerosing pneumocytomas are rare benign tumors, with some cases demonstrating potential for aggressive metastasis. Patients typically are asymptomatic with a nodule/mass seen on incidental imaging; however, they can present with nonspecific symptoms such as cough, shortness of breath, and chest pain. Diagnosis can only be confirmed with biopsy, and computed tomography-guided or fluoroscopy-guided needle biopsies are routinely used. Yet, with the advancement of technology and increased physician proficiency, robotic bronchoscopy can be safely and effectively used to obtain a tissue diagnosis. In this report, we present two cases of sclerosing pneumocytoma tumors. The first case was an incidentally encountered tumor that was found to be hypermetabolic on positron emission tomography (PET) imaging. It was diagnosed using robotic bronchoscopy and resected via lobectomy. The second case was an incidentally encountered tumor that was hypometabolic on PET imaging. It was diagnosed after wedge resection, which also revealed an adjacent carcinoid tumorlet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.